Ascletis Pharma (FRA:2VJ) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2VJ Ascletis Pharma Inc FRA:2VJ
40 GF Score
Price €0.97
GF Value €0.02
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Ascletis Pharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:2VJ vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Ascletis Pharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascletis Pharma Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascletis Pharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Ascletis Pharma's Short Percentage of Float falls into.


FRA:2VJ
40GF Score
Ascletis Pharma Inc FRA:2VJ
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ascletis Pharma (FRA:2VJ) Overvalued in 2026?

Based on GuruFocus' analysis, Ascletis Pharma stock appears to be overvalued. The current stock price of €0.97 is trading 4725% above its estimated GF Value™ of €0.02. GuruFocus considers Ascletis Pharma to be Significantly Overvalued.

Key valuation signals for FRA:2VJ:

  • Short Percentage of Float:
  • GF Value™: €0.02 vs. price of €0.97 (4725% above fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the FRA:2VJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ascletis Pharma Business Description

Other Exchanges ASCLF:USA01672:Hong Kong
Address No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, HKG, 311200
Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. The drug candidates of the company in the pipeline in their different stages of development such as ASC30, ASC47, ASC39, ASC36i, ASC35, ASC50, and among others.
40GF Score

Get the complete analysis for FRA:2VJ

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.97
Price
€0.02
GF Value